TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14668 · May 3

#svelte#component#component_library#components#css#css_components#css_framework#daisyui#design_pattern#design_system#design_systems#postcss#svelte#tailwind#tailwind_css#tailwindcss#ui_design#ui_framework#ui_kit#ui_library#ui_pattern daisyUI is a popular, free, and open-source component library for Tailwind CSS. It helps you build faster by providing useful class names for common UI elements like cards and calendars. This means you write less code and can focus on designing your interface more efficiently. daisyUI is also very customizable and works well with Next.js, adding no extra JavaScript to your projects, which keeps them fast and efficient. Overall, using daisyUI simplifies your development process and makes your projects more maintainable. https://github.com/saadeghi/daisyui

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选
Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment